Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry

AIMS: To evaluate the long-term use of secondary prevention medications [statins, β-blockers, renin–angiotensin–aldosterone system (RAAS) inhibitors, and platelet inhibitors] after coronary artery bypass grafting (CABG) and the association between medication use and mortality. METHODS AND RESULTS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Björklund, Erik, Nielsen, Susanne J, Hansson, Emma C, Karlsson, Martin, Wallinder, Andreas, Martinsson, Andreas, Tygesen, Hans, Romlin, Birgitta S, Malm, Carl Johan, Pivodic, Aldina, Jeppsson, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194184/
https://www.ncbi.nlm.nih.gov/pubmed/31638654
http://dx.doi.org/10.1093/eurheartj/ehz714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194184/
https://www.ncbi.nlm.nih.gov/pubmed/31638654
http://dx.doi.org/10.1093/eurheartj/ehz714

Ejemplares similares